Hyperphagia and hyperleptinemia induced by low-protein, high-carbohydrate diet is reversed at a later stage of development in rats

Abstract

This study investigated whether increased food intake after 15 days of low-protein, high-carbohydrate (LPHC) and its normalization in the later period of development change the content of key proteins related to leptin or adiponectin signaling in the hypothalamus. Male rats were divided into five groups: Control groups received a control diet (17% protein, 63% carbohydrate) for 15 (C₁₅) or 45 (C₄₅) days; LPHC groups received an LPHC diet (6% protein, 74% carbohydrate) for 15 (LPHC₁₅) or 45 (LPHC₄₅) days; and Reverse group (R): received LPHC diet for 15 days followed by control diet for another 30 days. The LPHC₁₅ group showed increased adiposity index, leptin level, and adiponectin level, as well as decreased the leptin receptor (ObRb) and pro-opiomelanocortin (POMC) content in the hypothalamus compared with the C₁₅ group. LPHC diet for 45 days or diet reversion (R group) rescued these alterations, except the adiponectin level in LPHC₄₅ rats, which was higher. In summary, LPHC diet reduced hypothalamic leptin action by diminishing ObRb and POMC levels, leading to hyperphagia and adiposity body. Medium-term administration of LPHC diet or reverting to control diet restored the levels of these proteins, thereby improving body lipid mass rearrangement in adulthood.

Key words
adiponectin; hypothalamus; low-protein high-carbohydrate diet; leptin

INTRODUCTION

Living organisms have fuel storage mechanisms because an adequate supply of nutrients is essential for the maintenance of life and health. Consuming more calories than is required leads to the storage of energy as triacylglycerol (TAG) in white adipose tissues for later use. Uninterrupted ingestion of food, which is associated with sedentary life, has increased the prevalence of obesity worldwide in the last several decades (Ford et al. 2004, Fisberg et al. 2016). High content of body lipids has also been associated with low consumption of protein (Meyers & Hargus 1959, White et al. 2000a), and when the protein level does not deviate far from the minimum required amount, the elevation in lipid content is related to increased food intake (Peng et al. 1974, White et al. 1994, 2000b, Du et al. 2000, Aparecida de França et al. 2009).

Food intake is important for the maintenance of energy homeostasis. This physiologic function in higher animals is regulated by a complex system involving the neuro-endocrine system. Several brain areas participate in this process. The arcuate nucleus (ARC) in the hypothalamus is the primary site that transduces peripheral clues into neural responses and regulates food intake and body weight (Timper & Brüning 2017). Leptin is one of the peripheral signals acting on hypothalamic neurons, and its level in plasma is proportional to body fat content (Kwon et al. 2016). The ARC contains a population of leptin-sensitive neurons, which express orexigenic peptides such as neuropeptide Y (NPY) and agouti-related protein (AgRP). Another population of neurons express peptides such as pro-opiomelanocortin (POMC) and cocaine and amphetamine related transcript (CART), which suppress food intake. The binding of leptin to its receptor in neurons of the ARC stimulates POMC/CART neurons and inhibits NPY/AgRP neurons (Lanfray & Richard 2017)

Studies conducted in our laboratories with rats in the growing phase subjected to low-protein, high-carbohydrate diet (LPHC) for 15 days showed an increase in food intake associated with an increase in the absolute and/or relative body lipid content compared with rats treated with a balanced diet. The LPHC diet also induced a 100% increase in serum leptin and a decrease in postprandial insulin level (Aparecida de França et al. 2009). We have also investigated the profile of rats subjected to the LPHC diet for 45 days, and of rats provided with the LPHC diet for 15 days followed by a balanced diet for 30 days (Ceolin et al. 2019). The rats treated with LPHC diet for 45 days exhibited increases in food intake, body lipid content, and serum adiponectin levels. However, the leptin and fed insulin levels of these rats were similar to those of control diet-fed rats (Ceolin et al. 2019). Rats that had the LPHC diet replaced with a control diet showed hyperinsulinemia and increased food intake during the 45 days of treatment; however, their serum leptin and adiponectin levels were similar to those of rats fed a balanced diet for 45 days (Ceolin et al. 2019).

Studies showed that overfeeding in the early phases of life can lead to hyperinsulinism and interfere with the programming of the neuroendocrine system (Plagemann 2006, Bouret 2009, Reynolds et al. 2017). Acquired insulin and leptin resistance have also been suggested in these cases (Habbout et al. 2013). Elevated serum triiodothyronine or adiponectin can stimulate the AMP-Activated Protein Kinase (AMPK) pathway in the hypothalamus, inducing similar programming with an increase in food intake. AMPK can also mediate the fatty acid oxidation induced by leptin and adiponectin in skeletal muscles (Stark et al. 2013, Stern et al. 2016). Moreover, reduced AMPK activity in the hypothalamus can lead to reduced food intake and enhanced energy expenditure (López 2018).

In the condition of overfeeding during the early phases of development, instead of a leptin deficiency, high circulating levels of the hormone are observed, which is associated with a loss of leptin responsiveness (Stefanidis & Spencer 2012, Castro et al. 2015). Based on these data and considering the results of our previous studies in rats fed an LPHC diet, we hypothesized that the alterations in food intake, which are associated with high body lipid accumulation, may be related with changes in the action of leptin, adiponectin, or both in the hypothalamus. Thus, our objective in the present study was to test this hypothesis. For this, we assessed the effects of LPHC diet for 15 and 45 days on plasma leptin and adiponectin hormone levels, white adipose tissue weight, and hypothalamic protein levels involved in the leptin and AMPK signaling pathways. Additionally, we investigated whether 15 days of LPHC diet followed by its replacement with a balanced diet in the later period of development can significantly modulate food intake and adiposity by altering the expression of proteins involved in the action of leptin and/or adiponectin in the hypothalamus.

MATERIALS AND METHODS

Animals and diets

The rats were treated with two types of diet: control (C) diet containing 17% of protein, 63% carbohydrate, and 7% lipid (AIN-93G) (Reeves et al. 1993); and LPHC diet containing 6% of protein, 74% carbohydrate, and 7% lipid. The diet composition details have been published previously (Aparecida de França et al. 2009). The amount of calories corresponding to the protein withdrawn from the LPHC diet was compensated by adding the same amount of calories in the form of carbohydrates. Thus, the diets were kept isocaloric (16.3 kJ g^-1) (Aparecida de França et al. 2009, Santos et al. 2012, Buzelle et al. 2010, Menezes et al. 2013, Pereira et al. 2017, Silva et al. 2018). Male Wistar rats aged 30 days and weighing 100 g were randomly divided into five groups: (i) C₁₅, rats fed the C diet for 15 days; (ii) LPHC₁₅, rats fed the LPHC diet for 15 days; (iii) C₄₅, rats fed the C diet for 45 days; (iv) LPHC₄₅, rats fed the LPHC diet for 45 days; (v) R, rats fed the LPHC diet for 15 days, followed by replacement with the C diet for the subsequent 30 days.

The rats were housed in individual metabolic cages in an environmentally controlled room with lights on from 6 a.m. to 6 p.m. and a temperature of 22 ± 1°C. They received water and food ad libitum. The body weight and food intake of each rat were recorded daily. All experiments were performed between 08:00 and 10:00 a.m., and the rats were euthanized on the 15^th (C₁₅ and LPHC₁₅ groups) or 45^th (C₄₅, LPHC₄₅, and R groups) day of treatment. The rats were housed according to the Brazilian College of Animal Experimentation Rules, and the experiments were approved by the Ethics Committee of the Federal University of Mato Grosso (protocol no. 23108.109377/2015-15).

Sample collection

After the experiment, the rats were euthanized by decapitation. Blood samples were collected, and serum was obtained by centrifugation (3,000 rpm for 10 minutes) for measurement of leptin and adiponectin concentrations. Retroperitoneal, epididymal, and perirenal white adipose tissues were removed and weighed. The hypothalamus was collected to determine the content of the leptin receptor (ObRb), proteins of the leptin signaling pathway (JAK2, p-JAK2, STAT3, p-STAT3, SOCS3), neuropeptides (NPY, POMC), AMPK, and p-AMPK via western blotting analyses.

Adiposity index

The adiposity index was determined from the sum of the weight of retroperitoneal, epididymal, and perirenal white adipose tissues. The results were expressed as percentage of the total body weight.

Hormonal analysis

Serum leptin concentration was measured using a rat leptin Elisa kit (limit of detection: 50 pg/mL of sample; Société de Pharmacologie et d’Immunologie – BIO, Montignyle Bretonneux, France). Serum adiponectin was measured using a rat adiponectin Elisa kit (limit of detection: 0.4 ng/mL of sample; R&D Systems, Minneapolis, MN, USA).

Western blotting protein analysis

Hypothalamus samples were homogenized in ice-cold lysis buffer pH 6.4 (50 mM HEPES, 1 mM MgCl₂, 10 mM EDTA, Triton X-100 1%, 5 µg mL^-1aprotinin, 1 µg mL^-1 leupeptin, 1 mM phenylmethylsulfonyl fluoride, 10 mM sodium orthovanadate, 100 mM sodium fluoride, and 10 mM tetrasodium pyrophosphate). Homogenates were centrifuged at 4°C and 10,000 rpm for 5 min. Protein concentration was determined via Bradford assay (1976). Protein samples were denatured in sample buffer (50 mM Tris·HCl pH 6.8, 1% SDS, 5% 2-mercaptoethanol, 10% glycerol, and 0.001% bromophenol blue) and heated at 95°C for 5 min.

The supernatants were analyzed by the SDS-PAGE method using 8%, 10%, or 12% polyacrylamide gel, with 30 µg or 50 µg of total proteins in each slot of the gel. Next, the gel was electroblotted in a nitrocellulose membrane (Hybond P ECL membrane; Amersham Pharmacia Biotech, Sweden). The membrane was then incubated in Tris Buffered Saline (TBS) containing 5% of nonfat dry milk for 60 min to block nonspecific binding sites. Next, the membrane was washed with TBS and incubated overnight with the following primary antibodies (Santa Cruz Biotechnology, USA.): anti-Ob-R (1:200); anti-phosphorylated (p) JAK2 (1:500); anti-JAK2 (1:200); anti-STAT3 (1:500); anti-phosphorylated (p) STAT3 (1:500); anti-SOCS3 (1:500); anti-β actin (1:500); POMC (1:200); (Sigma Aldrich, USA.): NPY (1:3000); (Cell Signaling, USA.): anti-phosphorylated (p) anti-AMPK (1:1000); and AMPK (1:1000). Furthermore, the membrane was washed and incubated with the appropriate secondary antibodies conjugated to biotin (0.5% nonfat dry milk diluted in TBS; Santa Cruz Biotechnology) for 1 h at 25°C. The membrane was subsequently washed and incubated for 1 h at 25°C with streptavidin horseradish peroxidase-conjugated secondary antibody (1:5000 or 1:10000; Zymed, California). Immunoreactive proteins were visualized by horseradish peroxidase substrate (ECL-plus; Amersham Pharmacia Biotech) and then exposed to an X-ray film. Finally, the area and density of the protein bands were quantified by using the Image J Program (Wayne Rasband, National Institutes of Health, New York, NY)

The band intensity of phosphorylated JAK2, phosphorylated STAT3, and phosphorylated AMPK was normalized to that of the total JAK2, STAT3, and AMPK, respectively. For the other proteins, the band intensity was normalized to that of β-actin.

Statiscal analyses

The test results were expressed as mean ± standard error of the mean. Data were subjected to statistical analyses using the Statistics for Windows program (StatSoft, USA). Levene’s test for homogeneity of variances was initially used to determine whether the data complied with the assumptions of parametric analysis of variance. Differences between groups were analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s post-hoc test or Student’s t-test for independent samples. Differences were considered significant at p>0.05.

RESULTS

The energy intake (daily and total) of the LPHC₁₅ group was 28% higher than that of the C₁₅ group (Table I). The LPHC₁₅ group showed an approximately 74% increase in body weight over 15 days, whereas the C₁₅ group showed an approximately 104% increase (Table II), compared with the respective initial weights. The energy intake (daily and total) of the LPHC₄₅ and R groups was 22% and 11% higher, respectively, than that of the C₄₅ group (Table I). Despite the increased energy intake in the LPHC₁₅ and LPHC₄₅ groups, the total protein intake (g/100g b.w.) was approximately 55% lower than that of their respective controls. The R group showed increased protein intake (g/100g b.w.) compared with the LPHC₄₅ group, but in the same period, the protein intake was 24% lower than that of the C₄₅ group (Table I).

Table I
Relative values of daily and total energy intake and total protein intake in the C₁₅, LPHC₁₅, C₄₅, LPHC₄₅, and R groups.

	Groups
	C15 n=10	LPHC15 n = 9	C 45 n=10	LPHC 45 n= 10	R n=10
Daily energy intake (kJ/day)	173.2±4.5a	222.1±4.5b	135.0±3.3a	166.0±4.5b	150.3±3.4c
Total energy intake (kJ)	2627.6±83.2a	3334.4±77.8b	6076.2±147.9a	7433.1±205.6b	6763.3±151.0c
Total protein intake (g/100g b.w.)	27.1±0.7a	12.3±0.2b	63.3±1.4a	27.5±0.8b	47.8±1.1c

• Data are expressed as mean ± standard error of the mean (M ± SEM), n = number of animals. One-way ANOVA test for 45 days of treatment and Student’s t-test for 15 days of treatment. Different letters represent significant differences (p<0.05; C₁₅ vs LPHC₁₅; C₄₅ vs LPHC₄₅ vs R.

Table II
Initial and final body mass as well as body mass gain in the C₁₅, LPHC₁₅, C₄₅, LPHC₄₅, and R groups.

Variables	Groups
	C 15 (n=10)	LPHC 15 (n=9)	C 45 (n=11)	LPHC 45 (n=10)	R (n=10)
Initial body mass (g)	93.4±3.6a	95.5±3.3a	93.9±3.3 a	95.8±2.9 a	93.6±2.0 a
Final body mass (g)	190.7±7.6a	166.2±7.6 b	343.3±11.0a	273.9±10.5b	338.9±6.2a
Body weight gain (g/day)	6.2±0.3a	4.6±0.5 b	5.5±0.2a	4.0±0.2b	5.4±0.2a

• Data are expressed as mean ± standard error of the mean (M ± SEM), n = number of animals. One-way ANOVA test for 45 days of treatment and Student’s t-test for 15 days of treatment. Different letters represent significant differences (p<0.05; C₁₅ vs LPHC₁₅; C₄₅ vs LPHC₄₅ vs R.

The daily body mass gain in rats subjected to LPHC diet (LPHC₁₅ and LPHC₄₅ group) was lower than that in their respective control groups (C₁₅ and C₄₅, respectively). These differences resulted in the lower final body mass of the LPHC₁₅ (12%) and LPHC₄₅ (20%) groups than that of the C₁₅ and C₄₅ groups, respectively.

In the R group, after the LPHC diet was substituted with the C diet, the daily body mass gain increased. Moreover, after 5 days, the body mass of the R group was similar to that of the C₄₅ group (Table II).

LPHC₁₅ rats had significantly increased adiposity index (39%) and higher retroperitoneal (27%) and epididymal (22%) white adipose tissue weight than the control rats (Table III). There was no difference in perirenal white adipose tissue weight after 15 days between the diets. The diet also did not alter white adipose tissue weight and adiposity index after 45 days (Table III).

Table III
White adipose tissue weight and adiposity index of the C₁₅, LPHC₁₅, C₄₅, LPHC₄₅, and R groups.

Variables	Groups
	C15 (n=10)	LPHC15 (n=10)	C45 (n=9)	LPHC45 (n=9)	R (n=8)
Retroperitoneal WAT (g)	1.70±0.14a	2.15±0.13b	7.53±0.55 a	7.03±0.48 a	7.33±0.57 a
Epididymal WAT (g)	1.91±0.12a	2.32±0.15 b	7.31±0.56 a	7.14±0.46 a	7.77±0.78 a
Perirenal WAT (g)	0.32±0.05a	0.34±0.04a	1.43±0.16 a	1.21±0.13 a	1.32±0.12 a
Adiposity index (%)	2.04±0.09a	2.84±0.12b	4.89±0.39 a	5.76±0.45 a	4.90±0.46 a

• Data are expressed as mean ± standard error of the mean (M ± SEM), n = number of animals. One-way ANOVA test for 45 days of treatment and Student’s t-test for 15 days of treatment. Different letters represent significant differences (p<0.05; C₁₅ vs LPHC₁₅; C₄₅ vs LPHC₄₅ vs R.

Serum leptin level was 100% higher in the LPHC₁₅ group than in the C₁₅ group, but similar between the R and C₄₅ groups (Figure 1). Serum adiponectin was 120% higher in the LPHC₁₅ group than in the C₁₅ group (C₁₅= 5.3 ± 0.5 µg/mL and LPHC₁₅= 11.9 ± 0.3 µg/mL; (n=8 rats in both groups); p<0.0001). Serum adiponectin levels in the LPHC₄₅ and R groups have been previously presented by Ceolin et al. 2019. The authors showed that plasma adiponectin concentration in LPHC₄₅ rats was two-fold higher than that in C₄₅ and R rats, but similar between the C₄₅ and R groups.

Figure 1
Serum leptin of (a) the C₁₅ and LPHC₁₅ groups as well as (b) the C₄₅, LPHC₄₅, and R groups. Data are expressed as mean ± standard error of the mean (M ± SEM) of 7-10 rats per group. One-way ANOVA test for 45 days of treatment and Student’s t-test for 15 days of treatment. Different letters represent significant differences (p<0.05; C₁₅ vs LPHC₁₅; C₄₅ vs LPHC₄₅ vs R.

ObRb content was reduced by 40% after 15 days of treatment with the LPHC diet compared with that in the control (C₁₅) group (Figure 2a). The content of proteins in leptin signaling, namely JAK2, basal p-JAK2, STAT3, basal p-STAT3 (Figure 2), and SOCS3 (Figure 3a), in the hypothalamus was not altered in the LPHC₁₅ group compared with that in the C₁₅ group. The diet did not alter orexigenic NPY peptide content (Figure 3b). However, POMC content was reduced by approximately 30% in (Figure 3c) after 15 days of the LPHC diet. Furthermore, both the LPHC₄₅ and R groups showed no alteration in the content of ObRb (Figure 2b), NPY (Figure 3b), POMC (Figure 3c), and proteins of leptin signaling (Figure 2b) compared with the control group (C₄₅). The levels of AMPK and basal p-AMPK proteins, which are involved in the regulation of food intake, were also unaltered between the groups (Figure 4a and 4b). Figure 5 shows the schematic representation of leptin signaling in the hypothalamus of rats subjected to LPHC diet for 15 days.

Figure 2
Content of the long form of the leptin receptor (ObRb), JAK2, p-JAK2/JAK2, STAT3, and p-STAT3/STAT3 in the hypothalamus of the C₁₅ and LPHC₁₅ groups (a) as well as the C₄₅, LPHC₄₅, and R groups (b). Data are expressed as mean ± standard error of the mean (M ± SEM) of 6-8 rats per group. One-way ANOVA test for 45 days of treatment and Student’s t-test for 15 days of treatment. Different letters represent significant differences (p<0.05; C₁₅ vs LPHC₁₅; C₄₅ vs LPHC₄₅ vs R.

Figure 3
Content of SOCS3 (a), NPY (b), and POMC (c) in the hypothalamus of the C₁₅ and LPHC₁₅ as well as the C₄₅, LPHC₄₅, and R groups. Data are expressed as mean ± standard error of the mean (M ± SEM) of 6-8 rats per group. One-way ANOVA test for 45 days of treatment and Student’s t-test for 15 days of treatment. Different letters represent significant differences (p<0.05; C₁₅ vs LPHC₁₅; C₄₅ vs LPHC₄₅ vs R).

Figure 4
AMPK (a) and p-AMPK/AMPK (b) content in the hypothalamus of the C₁₅ and LPHC₁₅ groups as well as the C₄₅, LPHC₄₅, and R groups. Data are expressed as mean ± standard error of the mean (M ± SEM) of 6-8 rats per group. One-way ANOVA test for 45 days of treatment and Student’s t-test for 15 days of treatment.

Figure 5
Schematic representation of leptin signaling in the hypothalamus of rats subjected to LPHC diet for 15 days.

DISCUSSION

Previous studies by our group have indicated that after the administration of an LPHC diet for 15 days (LPHC₁₅ group), rats showed higher serum leptin concentrations and absolute and relative food intake and energy intake than the control rats (C₁₅). Despite the increase in food and energy intake, LPHC₁₅ rats had decreased final body weight (Aparecida de França et al. 2009). In the present work we also observed the same results in the LPHC₁₅. However, the LPHC₁₅ group showed increase (74% in body weight over 15 days), when compared with the respective initial weight. Despite, this a reduction in daily body mass gain (12%) was observed in LPHC₁₅ group. We believe that, although the energy intake is greater in the LPHC₁₅ group when compared with the C₁₅ group, the excess calories ingested are dissipated as heat. This was evidenced previously by the increase in mass and sympathetic flow in the brown adipose tissue (Aparecida de França et al. 2009) as well as the increase in the tissue temperature (Aparecida de França et al. 2014). In addition, our results previously also showed a reduction in the tissue protein synthesis both in the soleus (Batistela et al. 2014) and extensor digitorum longus muscles (Dos Santos et al. 2016). All of these factors together contribute to the reduction in body mass gain.

We also observed that rats subjected to medium-term LPHC diet (LPHC₄₅ group) and rats treated with LPHC diet for 15 days followed by control diet for 30 days (R group) showed higher total relative food intake than control (C₄₅) rats (Ceolin et al. 2019).

In the present study, we confirmed hyperleptinemia in LPHC₁₅ rats. Additionally, LPHC₁₅ rats exhibited higher adiposity index than C₁₅ rats. There is an evidence that hyperleptinemia and leptin resistance are directly associated with elevated adiposity and food intake (Maffei et al. 1995, Silva-Bertani et al. 2020, Gruber et al. 2021). Thus, it is possible that the hyperphagia observed in LPHC₁₅ rats was attributed to dysfunctional leptin signaling or leptin resistance in the hypothalamus, and not to leptin deficiency. To assess this possibility, we investigated the content of proteins related to leptin signaling in the hypothalamus in basal conditions.

We observed a reduction in ObRb content in LPHC₁₅ rats, which suggested a loss of leptin responsiveness in the hypothalamus. High fat-fed rats also showed leptin resistance with low ObRb content. In these rats, these effects appeared to be post-transcriptional, as equivalent changes were not observed in the expression of the long and short form mRNAs of the leptin receptor (Madiehe et al. 2000).

Leptin in the hypothalamus stimulates neurons that express anorexigenic peptides and inhibits orexigenic neurons. We measured the content of the orexigenic peptide NPY and anorexigenic peptide POMC in the hypothalamus of LPHC₁₅ rats. NPY peptide content was not different between the LPHC₁₅ and C₁₅ groups, but the content of POMC, which is a target for the programming of obesity (Stevens et al. 2011), was lower. There is also an evidence that maternal undernutrition can lead to epigenetic changes in the gene promoter of POMC in the fetus (Stevens et al. 2011). Studies in rodents have shown that hypothalamic programming can occur in both fetal and early postnatal lives (Coupé et al. 2010). In our experimental model, the LPHC diet was introduced when the rats were approximately 1 month old (after weaning). DNA methylation or histone modification by acetylation or methylation (Ho & Tang 2007) are epigenetic modifications that transcriptionally silence or activate genes, thereby altering the structure of chromatin. DNA methylation is associated with gene silencing, and its effects are thought to be permanent. The obese human phenotype is associated with POMC gene methylation and reducted POMC expression, resulting in elevated food intake. Thus, the results of the present study suggested that the reduction in POMC concentration in the LPHC₁₅ group may be caused by impairment of leptin signaling, which negatively modulated hypothalamic POMC gene expression.

We also determined whether medium-term LPHC diet (LPHC₄₅ group) or replacement of the 15-day LPHC diet with control diet for 30 days (R group) can reverse this dysfunction and normalize the content of proteins involved in leptin signaling in the hypothalamus. The levels of leptin in the serum as well as ObRb and POMC in the hypothalamus of the LPHC₄₅ and R groups were similar to those of the C₄₅ group, indicating that the loss leptin responsivity induced by 15 days of LPHC diet was not maintained until the 45^th day of this diet nor after reverting to a balanced diet (R group). Despite this improvement of leptin sensitivity, the LPHC₄₅ and R groups did not display a significant reduction in food intake. However, the white adipose tissue mass and adiposity index of R and LPHC₄₅ rats were similar to those of C₄₅ rats. Therefore, this enhancement of leptin sensitivity induced by the LPHC diet may improve the body lipid mass rearrangement which, in turn, can improve obesity outcomes.

Intriguingly, the R group did not show increased body mass gain after the diet was changed (Table II), despite the lower duration of the control diet treatment. This fact showed that the limited increase in body mass in the LPHC group was not caused by calory intake but was certainly caused by the low protein content of the diet.

To evaluate the possible participation of adiponectin in the normalization of the relative food intake and POMC content in adult rats (LPHC₄₅ and R groups), AMPK and p-AMPK content in the hypothalamus was determined. Adiponectin stimulates food intake by activating AMPK (Kubota et al. 2007). Serum adiponectin concentration in the R group was the same as that in the C₄₅ group on the 45^th day (Ceolin et al. 2019), and the relative daily food intake was the same since the 20^th day of treatment, as noted previously by Ceolin et al. (2019). However, adiponectin concentration in the LPHC group was higher than that in the C₄₅ and R groups (Ceolin et al. 2019). Adiponectin levels and relative food intake in the LPHC₁₅ group were also higher than those in the C₁₅ group. In the R group, which showed similar adiponectin concentrations to those of the C₄₅ group, the daily relative food intake decreased more rapidly than C₄₅ group (since the 20^th day of treatment) (Ceolin et al. 2019). We believe that in LPHC₄₅ rats, despite the high adiponectin concentration, adiponectin signaling in the hypothalamus was not altered because there were no changes in AMPK, p-AMPK, and p-STAT3 levels between the groups. Therefore, the increased food intake in the LPHC₄₅ group was not due to a loss in the hypothalamic signaling of leptin or adiponectin (considering that the content of key proteins of both signaling pathways was preserved), but occurred as an attempt to fulfill the protein requirement of the animals. We believe that high adiponectin concentration is an adaptation process contributing to the restoration of adiposity index when the central leptin sensibility was normalized in LPHC₄₅ rats. However, further experiments are required to elucidate the exact role of adiponectin in this process.

In conclusion, 15 days of LPHC diet treatment induced alterations in content of ObRb and POMC in the hypothalamus, causing hyperphagia, hyperleptinemia, and adiposity body. Treatment with medium-term LPHC diet or diet replacement with control diet normalized the hypothalamic leptin action and restored ObRb and POMC content, thus improving body lipid mass rearrangement in adulthood.

ACKNOWLEDGMENTS

We thank Dr. Nair Honda Kawashita (in memoriam) for her dedication in training her students and for great contribution to biochemistry research. We lost a brilliant researcher, teacher, and a great friend. This work was supported by grants from Fundação de Amparo à Pesquisa do Estado de Mato Grosso (FAPEMAT, Cuiabá, Brazil) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brasília, Brazil). This work is part of the dissertation presented by Mendalli Froelich as a partial requirement for the Master’s degree in Biosciences at School of Nutrition, UFMT.

REFERENCES

• APARECIDA DE FRANÇA S, DOS SANTOS MP, GAROFALO MA, NAVEGANTES LC, KETTELHUT IC, LOPES CF & KAWASHITA NH. 2009. Low protein diet changes the energetic balance and sympathetic activity in brown adipose tissue of growing rats. Nutrition 25: 1186-1192.
• APARECIDA DE FRANÇA ET AL. 2014. Low-protein, high-carbohydrate diet increases glucose uptake and fatty acid synthesis in brown adipose tissue of rats. Nutrition 30: 474-480.
• BATISTELA E ET AL. 2014. Decreased rate of protein synthesis, caspase-3 activity, and ubiquitin–proteasome proteolysis in soleus muscles from growing rats fed a low-protein, high-carbohydrate diet. Can J Phys Pharmacol 92(6): 445-454.
• BOURET SG. 2009. Early Life Origins of Obesity: Role of Hypothalamic Programming. J Pediatr Gastroenterol Nutr 48: S31-S38.
• BRADFORD MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
• BUZELLE SL, SANTOS MP, BAVIERA AM, LOPES CF, GARÓFALO MA, NAVEGANTES LC, KETTELHUT IC, CHAVES VE & KAWASHITA NH. 2010. A low protein, high-carbohydrate diet increases the adipose lipid content without increasing the glycerol-3-phosphate or fatty acid content in growing rats. Can J Physiol Pharmacol 88: 1157-1165.
• CASTRO H, POMAR CA, PICÓ C, SÁNCHEZ J & PALOU A. 2015. Cafeteria diet overfeeding in young male rats impairs the adaptive response to fed/fasted conditions and increases adiposity independent of body weight. Int J Obes (Lond) 39(3): 430-437.
• CEOLIN P ET AL. 2019. A low-protein, high carbohydrate diet induces increase in serum adiponectin and preserves glucose homeostasis in rats. An Acad Bras Cienc 91: e20180452.
• COUPÉ B, AMARGER V, GRIT I, BENANI A & PARNET P. 2010. Nutritional programming affects hypothalamic organization and early response to leptin. Endocrinology 151: 702-713.
• DOS SANTOS MP ET AL. 2016. Higher insulin sensitivity in EDL muscle of rats fed a low-protein, high-carbohydrate diet inhibits the caspase-3 and ubiquitin-proteasome proteolytic systems but does not increase protein synthesis. J Nutr Biochem Aug 34: 89-98.
• DU F, HIGGINBOTHAM DA & WHITE BD. 2000. Food intake, energy balance and serum leptin concentrations in rats fed low-protein diets. J Nutr 130(3): 514-421.
• FISBERG M, MAXIMINO P, KAIN J & KOVALSKYS I. 2016. Obesogenic environment – intervention opportunities. J Pediatr 92: S30-S39.
• FORD ES, GILES WH & MOKDAD AH. 2004. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 27(10): 2444-2449.
• GRUBER T ET AL. 2021. Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promotehypertension. Cell Metabolism 1155-1170.
• HABBOUT A, LI N, ROCHETTE L & VERGELY C. 2013. Postnatal overfeeding in rodents by litter size reduction induces major short- and long-term pathophysiological consequences. J Nutr 143(5): 553-562.
• HO SM & TANG WY. 2007. Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases. Reprod Toxicol 23(3): 267-682.
• KUBOTA N ET AL. 2007. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6(1): 55-68.
• KWON O, KIM KW & KIM MS. 2016. Leptin signalling pathways in hypothalamic neurons. Cellular and Molecular Life Sciences 73: 1457-1477.
• LANFRAY D & RICHARD D. 2017. Emerging Signaling Pathway in Arcuate Feeding-Related Neurons: Role of the Acbd. Front Neurosci 11: 328-335.
• LÓPEZ M. 2018. Hypothalamic AMPK and energy balance. Eur J Clin Invest 48: e12996.
• MADIEHE AM, SCHAFFHAUSER AO, BRAYMER DH, BRAY GA & YORK DA. 2000. Differential expression of leptin receptor in high- and low-fat-fed Osborne-Mendel and S5B/Pl rats. Obes Res 8(6): 467-474.
• MAFFEI M ET AL. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11): 55-61.
• MENEZES AL ET AL. 2013. A Low-protein, high carbohydrate diet increases de novo fatty acid synthesis from glycerol and glycerokinase content in the liver of growing rats. Nutr Res 33(6): 494-502.
• MEYERS JH & HARGUS WA. 1959. Factors influencing food intake of rats fed low-protein rations. Am J Physiol 197(6): 1350-1352.
• PENG YS, MELIZA LL, VAVICH MG & KEMMERER AR. 1974. Changes in food intake and nitrogen metabolism of rats while adapting to a low or high protein diet. J Nutr 104(8): 1008-1017.
• PEREIRA MP, FERREIRA LAA, DA SILVA FHS, CHRISTOFFOLETE MA, METSIOS GS, CHAVES VE, DE FRANÇA SA, DAMAZO AS, FLOURIS AD & KAWASHITA NH. 2017. A low-protein, high-carbohydrate diet increases browning in perirenal adipose tissue but not in inguinal adipose tissue. Nutrition 42: 37-45.
• PLAGEMANN A. 2006. Perinatal nutrition and hormone-dependent programming of food intake. Horm Res 65(Suppl 3): 83-89.
• REEVES PG, NIELSEN FH & FAHEY GC JR. 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.
• REYNOLDS CM, SEGOVIA SA & VICKERS MH. 2017. Experimental Models of Maternal Obesity and Neuroendocrine Programming of Metabolic Disorders in Offspring. Front Endocrinol (Lausanne) 8: 245.
• SANTOS MP, FRANCA SA, SANTOS JT, BUZELLE SL, BERTOLINI GL, GARÓFALO MA, KETTELHUT IC, FRASSON D, CHAVES VE & KAWASHITA NH. 2012. A low-protein, high-carbohydrate diet increases fatty acid uptake and reduces norepinephrine-induced lipolysis in rat retroperitoneal white adipose tissue. Lipids 47: 279-289.
• SILVA FHSD, DOS SANTOS MP, PEREIRA MP, BUZELLE SL, ALLEBRANDT NETO EW, GAI BM, CORREIA FDS, ALVES CH, APARECIDA DE FRANÇA S & KAWASHITA NH. 2018. The antioxidant system in the soleus muscle of growing rats is stimulated by the administration of a low-protein/high-carbohydrate diet. Arch Physiol Biochem 29: 1-8.
• SILVA-BERTANI DCTD ET AL. 2020. Decreased Collagen Type I is Associated with Increased Metalloproteinase-2 Activity and Protein Expression of Leptin in the Myocardium of Obese Rats Arq Bras. Cardiol 115: 61-69.
• STARK R, ASHLEY S & ANDREWS ZB. 2013. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Molecular and Cellular Endocrinology 366: 215-223.
• STEFANIDIS A & SPENCER SJ. 2012. Effects of neonatal overfeeding on juvenile and adult feeding and energy expenditure in the rat. PLoS ONE 7(12): e52130.
• STERN JH, RUTKOWSKI JM & SCHERER PE. 2016. Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis Through Adipose Tissue Crosstalk. Cell Metab 23: 770-784.
• STEVENS A, BEGUM G & WHITE A. 2011. Epigenetic changes in the hypothalamic pro-opiomelanocortin gene: a mechanism linking maternal undernutrition to obesity in the offspring?Eur J Pharmacol 660(1): 194-201.
• TIMPER K & BRÜNING JC. 2017. Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity. Dis Model Mech 10(6): 679-689.
• WHITE BD, HE B, DEAN RG & MARTIN RJ. 1994. Low protein diets increase neuropeptide Y gene expression in the basomedial hypothalamus of rats. J Nutr 124(8): 1152-1160.
• WHITE BD, PORTER MH & MARTIN RJ. 2000a. Effects of age on the feeding responsive to moderately low dietary protein in rats. Physiol Behav 68(5): 673-681.
• WHITE BD, PORTER MH & MARTIN RJ. 2000b. Protein selection, food intake, and body composition in response to the amount of dietary protein. Physiol Behav 69(4-5): 383-392.

Publication Dates

• Publication in this collection
  15 July 2022
• Date of issue
  2022

History

• Received
  18 June 2021
• Accepted
  04 Oct 2021